Plain-English translation of NCT06244355 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Researchers are studying specific types of white blood cells called neutrophils in people with lung cancer to understand why some patients respond well to immunotherapy while others do not. By analyzing blood samples from lung cancer patients, people with chronic lung disease, and healthy volunteers, the team hopes to identify patterns that could predict which patients will benefit from immunotherapy and potentially discover new treatment targets.
Currently, 80% of lung cancer patients do not respond well to immunotherapy and their cancer progresses quickly. This trial exists to identify early warning signs in blood samples that could help doctors predict who will respond to treatment and adjust care plans sooner, or find new ways to help patients who might otherwise not benefit.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will donate blood samples that researchers will analyze to study your white blood cells. The study compares blood patterns from three groups: people newly diagnosed with metastatic lung cancer, people with chronic lung disease from smoking, and healthy volunteers. Your participation helps researchers identify which blood cell patterns predict good or poor response to immunotherapy, potentially improving treatment decisions for future patients.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
France